Publication: Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/μL
Issued Date
2007-11-01
Resource Type
ISSN
09564624
Other identifier(s)
2-s2.0-38449109809
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of STD and AIDS. Vol.18, No.11 (2007), 782-786
Suggested Citation
Weerawat Manosuthi, Somnuek Sungkanuparph, Somsit Tansuphaswadikul, Yaowarat Inthong, Wisit Prasithsirikul, Suthat Chottanapund, Wiroj Mankatitham, Sukanya Chimsuntorn, Chayanan Sittibusaya, Visal Moolasart, Nopphanath Chumpathat, Patamavadee Termvises, Achara Chaovavanich Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/μL. International Journal of STD and AIDS. Vol.18, No.11 (2007), 782-786. doi:10.1258/095646207782212289 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/24502
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/μL
Other Contributor(s)
Abstract
The objective of the study was to determine cumulative incidence and risk factors of nevirapine (NVP)-associated rashes that lead to NVP discontinuation among HIV-infected patients with CD4 <250 cells/μL. A retrospective cohort study was conducted among antiretroviral-naïve HIV-infected patients who had baseline CD4 <250 cells/μL and were initiated NVP-based antiretroviral therapy (ART) between January 2003 and October 2005. There were 910 patients with a mean age of 35.4 years and 43% were women. Median CD4 cell count was 27 cells/μL and median HIV RNA was 5.5 log copies/mL. Cumulative incidences of rashes at 0.5, 1, 2, 3 and 6 months after ART were 3.7%, 6.2%, 8.1%, 8.5% and 8.5%, respectively. By Kaplan-Meier analysis, the higher baseline CD4 cell counts had a higher probability of NVP-associated rashes (log-rank test, P = 0.041). By Cox regression analysis, higher baseline CD4 cell count was associated with a higher incidence of rashes (hazard ratio = 1.244, 95% confidence interval = 1.045-1.482, for every 50 cells/μL increment of baseline CD4 stratum). In conclusion, NVP-associated skin rashes that lead to NVP discontinuation are common among HIV-infected patients with baseline CD4 <250 cells/μL. Despite the low baseline in this population, the higher number of baseline CD4 cells is continuously associated with a higher risk for skin rashes.